MNPR
Monopar Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$60.36
+2.76 ▲ +4.79%
🌙 3월 13일 5:24 PM ET (한국 3/14 06:24)
$61.03
+0.67 ▲ +1.11%
| Index | RUT | P/E | - | EPS (ttm) | -3.44 | Insider Own | 34.2% | Shs Outstand | 0.01B | Perf Week | 4.77% |
| Market Cap | 0.40B | Forward P/E | - | EPS next Y | -101.25% | Insider Trans | -19.51% | Shs Float | 0.00B | Perf Month | 1.63% |
| Enterprise Value | 0.26B | PEG | - | EPS next Q | -0.45 | Inst Own | 73.53% | Short Float | 36.14% | Perf Quarter | -22.83% |
| Income | -0.02B | P/S | - | EPS this Y | 60.92% | Inst Trans | 21.12% | Short Ratio | 5.9 | Perf Half Y | 26.63% |
| Sales | 0.00B | P/B | 2.84 | EPS next 5Y | 2.31% | ROA | -25.88% | Short Interest | 1.59M | Perf YTD | -7.57% |
| Book/sh | 21.25 | P/C | 2.81 | EPS past 3/5Y | -4.06% -15.56% | ROE | -26.54% | 52W High | -42.51% ($105.00) | Perf Year | 104.68% |
| Cash/sh | 21.5 | P/FCF | - | Sales past 3/5Y | - | ROIC | -13.73% | 52W Low | 131.66% ($26.06) | Perf 3Y | 352.13% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -73.48% | Gross Margin | - | Volatility(W/M) | 5.77% 6.51% | Perf 5Y | 58.84% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 3.75 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 56.1 | EPS Q/Q | -30.26% | Profit Margin | - | RSI (14) | 55.15 | Recom | 1.15 |
| Dividend Gr. 3/5Y | - | Current Ratio | 56.1 | Sales Q/Q | - | SMA20 | 7.83% ($55.98) | Beta | 1.65 | Target Price | $112 |
| Payout | - | Debt/Eq | 0 | Earnings | 11000000 | SMA50 | -1.72% ($61.42) | Rel Volume | 1.24 | Prev Close | $57.6 |
| Employees | 16 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -24.06% - | SMA200 | 1.69% ($59.36) | Avg Volume(3M) | 0.27M | Price | $60.36 |
| IPO | 2019/12/19 | Option/Short | No/Yes | Trades | 3267 | Volume | 335,125 | Change | 4.79% |
뉴스 로딩 중...